fluorodeoxyglucose f18 has been researched along with Acute Chest Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brun-Buisson, C; de Prost, N; Dessap, AM; Deux, JF; Galactéros, F; Habibi, A; Itti, E; Maître, B; Meignan, M; Razazi, K; Sasanelli, M | 1 |
1 trial(s) available for fluorodeoxyglucose f18 and Acute Chest Syndrome
Article | Year |
---|---|
Positron Emission Tomography With 18F-Fluorodeoxyglucose in Patients With Sickle Cell Acute Chest Syndrome.
Topics: Acute Chest Syndrome; Adult; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neutrophil Infiltration; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |